125 related articles for article (PubMed ID: 25217220)
1. All-cause mortality and cardiovascular events with nicorandil in patients with IHD: systematic review and meta-analysis of the literature.
Luo B; Wu P; Bu T; Zeng Z; Lu D
Int J Cardiol; 2014 Oct; 176(3):661-9. PubMed ID: 25217220
[TBL] [Abstract][Full Text] [Related]
2. Effects of Nicorandil on All-Cause Mortality and Cardiac Events in CAD Patients Receiving PCI.
Zhang X; Yu Q; Yao X; Liu G; Li J; Du L
Int Heart J; 2019 Jul; 60(4):886-898. PubMed ID: 31308321
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
[TBL] [Abstract][Full Text] [Related]
4. Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study.
Horinaka S; Yabe A; Yagi H; Ishimitsu T; Yamazaki T; Suzuki S; Kohro T; Nagai R;
Circ J; 2010 Mar; 74(3):503-9. PubMed ID: 20081320
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness and safety of nicorandil in the treatment of patients with microvascular angina: A protocol for systematic review and meta-analysis.
Zhang Y; Wang X; Liu R; Li Q; Tian W; Lei H; Shi C
Medicine (Baltimore); 2021 Jan; 100(2):e23888. PubMed ID: 33466132
[TBL] [Abstract][Full Text] [Related]
6. Preventive effect of nicorandil on contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
Li S; Wang L; Liu Y; Hu Q
Intern Med J; 2018 Aug; 48(8):957-963. PubMed ID: 29740934
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of Chinese herbal medicine, Rhodiola formulation in treating ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials.
Yu L; Qin Y; Wang Q; Zhang L; Liu Y; Wang T; Huang L; Wu L; Xiong H
Complement Ther Med; 2014 Aug; 22(4):814-25. PubMed ID: 25146085
[TBL] [Abstract][Full Text] [Related]
8. Decreased cardiac mortality with nicorandil in patients with ischemic heart failure.
Yoshihisa A; Sato Y; Watanabe S; Yokokawa T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Takeishi Y
BMC Cardiovasc Disord; 2017 May; 17(1):141. PubMed ID: 28569214
[TBL] [Abstract][Full Text] [Related]
9. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
[TBL] [Abstract][Full Text] [Related]
10. The effect of nicorandil in patients with cardiac syndrome X: A meta-analysis of randomized controlled trials.
Jia Q; Shi S; Yuan G; Shi J; Shi S; Wei Y; Hu Y
Medicine (Baltimore); 2020 Sep; 99(37):e22167. PubMed ID: 32925783
[TBL] [Abstract][Full Text] [Related]
11. Obstructive sleep apnea and serious adverse outcomes in patients with cardiovascular or cerebrovascular disease: a PRISMA-compliant systematic review and meta-analysis.
Xie W; Zheng F; Song X
Medicine (Baltimore); 2014 Dec; 93(29):e336. PubMed ID: 25546682
[TBL] [Abstract][Full Text] [Related]
12. [Nicorandil in the treatment of patients with ischemic heart disease].
Minushkina LO; Sidorenko BA
Kardiologiia; 2013; 53(5):69-73. PubMed ID: 23952998
[TBL] [Abstract][Full Text] [Related]
13. Effect of nicorandil in patients with heart failure: a systematic review and meta-analysis.
Zhao F; Chaugai S; Chen P; Wang Y; Wang DW
Cardiovasc Ther; 2014 Dec; 32(6):283-96. PubMed ID: 25319832
[TBL] [Abstract][Full Text] [Related]
14. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
15. Intravenous nicorandil for patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.
Zhu Y; Xie S
Scand Cardiovasc J; 2023 Dec; 57(1):2220556. PubMed ID: 37376779
[TBL] [Abstract][Full Text] [Related]
16. Effect of aliskiren on cardiovascular outcomes in patients with prehypertension: a meta-analysis of randomized controlled trials.
Zhang JT; Chen KP; Guan T; Zhang S
Drug Des Devel Ther; 2015; 9():1963-71. PubMed ID: 25897206
[TBL] [Abstract][Full Text] [Related]
17. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
Fisher SA; Brunskill SJ; Doree C; Mathur A; Taggart DP; Martin-Rendon E
Cochrane Database Syst Rev; 2014 Apr; (4):CD007888. PubMed ID: 24777540
[TBL] [Abstract][Full Text] [Related]
18. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.
Nguyen PL; Je Y; Schutz FA; Hoffman KE; Hu JC; Parekh A; Beckman JA; Choueiri TK
JAMA; 2011 Dec; 306(21):2359-66. PubMed ID: 22147380
[TBL] [Abstract][Full Text] [Related]
19. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
Markham A; Plosker GL; Goa KL
Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
[TBL] [Abstract][Full Text] [Related]
20. Nicorandil improves clinical outcomes in patients with stable angina pectoris requiring PCI: a systematic review and meta-analysis of 14 randomized trials.
Li Y; Liu H; Peng W; Song Z
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):855-865. PubMed ID: 30079778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
